Medicine
Vivjoa 150 mg capsule
Vivjoa 150 mg capsule is a prescription medicine containing Oteseconazole for oral use, marketed by Mycovia Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Storage as on the product label
Key facts
- Active ingredient (INN)
- Oteseconazole
- Brand
- Vivjoa
- Strength
- 150 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 1 container
- Marketing authorisation holder
- Mycovia Pharmaceuticals
- Manufacturer
- Mycovia Pharmaceuticals
- Origin register
- US FDA, United States
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J02 Antifungals for systemic use
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 11 July 2022
- Identifiers
- RxCUI 2602582, 2602588, 2605802 +1DailyMed set ID e21d5008-800e-4417-927f-14340341865fNDC 74695-823Application NDA215888
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 container in 1 carton / 1 blister pack in 1 container / 18 capsule in 1 blister pack | 74695-823-18 | Mycovia Pharmaceuticals | 11 July 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Oteseconazole is an azole antifungal indicated to reduce the incidence of recurrent vulvovaginal candidiasis (RVVC) in females with a history of RVVC who are NOT of reproductive potential, among other approved uses. MedsAcross supplies Oteseconazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about OteseconazoleFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VIVJOA prescribing information (Mycovia Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Vivjoa 150 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.